References
- Auletta JJ, O'Riordan MA, Nieder ML. Infections in children with cancer: a continued need for the comprehensive physical examination. J Pediatr Hematol Oncol 1999;21:501–508.
- Santolaya ME, Alvarez AM, Becker A, . Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 2001; 19:3415–3421.
- Afzal S, Ethier MC, Dupuis LL, . Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia. Pediatr Infect Dis J 2009;28:1064–1068.
- Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783–801.
- Nieters A, Beckmann L, Deeg E, . Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun 2006;7:615–624.
- Peixoto-Rangel AL, Miller EN, Castellucci L, . Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9). Memorias Do Instituto Oswaldo Cruz 2009;104:1187–1190.
- Bochud PY, Chien JW, Marr KA, . Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008;359:1766–1777.
- Lanciotti M, Pigullo S, Lanza T, . Possible role of toll-like receptor 9 polymorphism in chemotherapy-related invasive mold infections in children with hematological malignancies. Pediatr Blood Cancer 2008;50:944.
- Agnese DM, Calvano JE, Hahm SJ, . Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002;186: 1522–1525.
- Sutherland AM, Walley KR, Russell JA. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 2005;33:638–644.
- Marshall GM, Haber M, Kwan E, . Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia. J Clin Oncol 2003;21:704–709.
- Perneger T. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236–1238.
- Soriano-Sarabia N, Vallejo A, Ramirez-Lorca R, . Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr 2008;49:128–135.
- Lehrnbecher T, Bernig T, Hanisch M, . Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia 2005;19:1745–1750.
- Miedema KG, te Poele EM, Tissing WJ, . Association of polymorphisms in the TLR4 gene with the risk of developing neutropenia in children with leukemia. Leukemia 2011;25:995–1000.